Cargando…

Prodromal Parkinson's disease: hype or hope for disease-modification trials?

The ultimate goal in Parkinson's disease (PD) research remains the identification of treatments that are capable of slowing or even halting the progression of the disease. The failure of numerous past disease-modification trials in PD has been attributed to a variety of factors related not only...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahlknecht, Philipp, Marini, Kathrin, Werkmann, Mario, Poewe, Werner, Seppi, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859908/ https://www.ncbi.nlm.nih.gov/pubmed/35184752 http://dx.doi.org/10.1186/s40035-022-00286-1

Ejemplares similares

The Concept of Prodromal Parkinson’s Disease
por: Mahlknecht, Philipp, et al.
Publicado: (2015)

Application of the Updated Movement Disorder Society Criteria for Prodromal Parkinson's Disease to a Population‐Based 10‐Year Study
por: Marini, Kathrin, et al.
Publicado: (2021)

The Gut and Parkinson’s Disease: Hype or Hope?
por: Scheperjans, Filip, et al.
Publicado: (2018)

Faecal Transplantation, Pro- and Prebiotics in Parkinson’s Disease; Hope or Hype?
por: Van Laar, T., et al.
Publicado: (2019)

Recent Advances in the Treatment of Genetic Forms of Parkinson’s Disease: Hype or Hope?
por: Cavallieri, Francesco, et al.
Publicado: (2023)

Nomogram to Predict the Probability of Functional Dependence in Early Parkinson’s Disease
por: Valent, Dora, et al.
Publicado: (2023)

Has Deep Brain Stimulation Changed the Very Long‐Term Outcome of Parkinson's Disease? A Controlled Longitudinal Study
por: Mahlknecht, Philipp, et al.
Publicado: (2020)

Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of NMS‐Nab Study
por: Peball, Marina, et al.
Publicado: (2022)

Role and clinical utility of pramipexole extended release in the treatment of early Parkinson’s disease
por: Hametner, Eva-Maria, et al.
Publicado: (2012)

Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
por: Carbone, Federico, et al.
Publicado: (2019)

Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone
por: Peball, Marina, et al.
Publicado: (2020)

Hope and hype
por: De Clercq, Erik
Publicado: (2006)

Application of a Simple Parkinson's Disease Risk Score in a Longitudinal Population‐Based Cohort
por: Marini, Kathrin, et al.
Publicado: (2020)

Disability Milestones and Death in Parkinson's Disease under Subthalamic Neurostimulation
por: Mahlknecht, Philipp, et al.
Publicado: (2023)

Nabilone for non-motor symptoms of Parkinson’s disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study)
por: Peball, Marina, et al.
Publicado: (2019)

Anticancer Drugs for Parkinson's Disease: Is It a Ray of Hope or Only Hype?
por: Dash, Deepa, et al.
Publicado: (2019)

Resveratrol for dry eye disease – Hope or Hype?
por: Shetty, Rohit, et al.
Publicado: (2023)

Cytokines in Schizophrenia: Hope or Hype?
por: Koola, Maju Mathew
Publicado: (2016)

How Does Deep Brain Stimulation Change the Course of Parkinson's Disease?
por: Mahlknecht, Philipp, et al.
Publicado: (2022)

Plant Microbiome Engineering: Hopes or Hypes
por: Afridi, Muhammad Siddique, et al.
Publicado: (2022)

Characterization of gait variability in multiple system atrophy and Parkinson’s disease
por: Sidoroff, Victoria, et al.
Publicado: (2020)

Personalized cardiac regeneration by stem cells–Hype or hope?
por: Becher, Ulrich Marc, et al.
Publicado: (2011)

Probiotic Supplements: Hope or Hype?
por: Wang, Yuxuan, et al.
Publicado: (2020)

Add-ons in IVF programme – Hype or Hope?
por: Datta, AK, et al.
Publicado: (2015)

The Hoops, Hopes, and Hypes of Human Microbiome Research
por: Bik, Elisabeth M.
Publicado: (2016)

Intervertebral Disc Nucleus Repair: Hype or Hope?
por: Tendulkar, Gauri, et al.
Publicado: (2019)

Regenerative and translational medicine in COPD: hype and hope
por: Guarnier, Lucas Pires, et al.
Publicado: (2023)

Mesenchymal stem cells in autoimmune diseases: hype or hope?
por: Scherer, Hans U, et al.
Publicado: (2010)

Undetected ophthalmological disorders in Parkinson’s disease
por: Borm, Carlijn D. J. M., et al.
Publicado: (2022)

Eye Tracking in Patients with Parkinson’s Disease Treated with Nabilone–Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study
por: Ellmerer, Philipp, et al.
Publicado: (2022)

Cell-free nucleic acid patterns in disease prediction and monitoring—hype or hope?
por: Crigna, Adriana Torres, et al.
Publicado: (2020)

Targeted Therapies in Early Stage NSCLC: Hype or Hope?
por: Friedlaender, Alex, et al.
Publicado: (2020)

Adjuvant Therapy for Renal Cell Carcinoma: Hype or Hope?
por: Cosso, Federica, et al.
Publicado: (2023)

Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
por: Meles, Sanne K., et al.
Publicado: (2021)

Enteroscopy in small-bowel Crohn’s disease (CD): hypes and hopes
por: Gecse, Krisztina B., et al.
Publicado: (2014)

Resveratrol for patients with chronic obstructive pulmonary disease: hype or hope?
por: Beijers, Rosanne J.H.C.G., et al.
Publicado: (2018)

Targeting the Gut Microbiota in Coronavirus Disease 2019: Hype or Hope?
por: Lau, Harry Cheuk-Hay, et al.
Publicado: (2022)

Anti-Interleukins for Severe Coronavirus Disease-2019: Hype or Hope?
por: Dimosiari, Athina, et al.
Publicado: (2022)

Microarrays for Bacterial Pathogens — Hope or Hype?
por: Wren, Brendan W.
Publicado: (2002)

PCR for the diagnosis of sepsis: hope or hype?
por: Schrenzel, Jacques
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ad0ao332299feeoucn1qg2gq2v